Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients with Non-segmental Vitiligo before and after phototherapy

This prospective study will include 30 patients with NSV, attending the Outpatient Clinics of Dermatology at Sohag University Hospitals, as well as 30 normal volunteers as control.

This study will be submitted for approval by Research and Ethical committees at Sohag Faculty of Medicine. An informed written consent will be obtained from each subject prior to participation in the study after full explanation of the procedure.

Inclusion Criteria:

• • Patients suffering from non segmental vitiligo.

  • Patients not on medical treatment or phototherapy for vitiligo in the last 3 months.

Exclusion Criteria:

• • Patients with systemic or cutaneous inflammatory disorders.

  • Patients on treatment for vitiligo in last 3 months.
  • Pregnant and lactating patients.
  • Patients with history of diabetes.
  • Patients with history of autoimmune diseases.